Clinical trial
A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Safety and Efficacy of KX-826 Tincture for Topical Use in Chinese Adult Female Patients With Androgenetic Alopecia (AGA)
NCT06409650 is registered in ClinicalTrials.gov with Suzhou Koshine Biomedica, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Safety and Efficacy of KX-826 Tincture for Topical Use in Chinese Adult Female Patients With Androgenetic Alopecia (AGA)
- Lead sponsor
- Suzhou Koshine Biomedica, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 9, 2021
- Completion date
- December 7, 2023
- Enrollment
- 160 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.